41 results on '"Rehwinkel H"'
Search Results
2. SEGRAs: A Novel Class of Anti-inflammatory Compounds
3. X-ray Structure of Human LDHA with an Allosteric Inhibitor (Compound 3)
4. X-ray Structure of Human LDH-A with an Allosteric Inhibitor (Compound 7)
5. Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases
6. Structure guided design and discovery of Indazole ethers as highly potent, non-steroidal Glucocorticoid receptor modulators
7. Discovery of New Selective Glucocorticoid Receptor Agonist Leads
8. ChemInform Abstract: Novel Prostanoid Thromboxane A2 Antagonists.
9. An attempt to synthesize prostanoid thromboxane A2 antagonists with an additional prostacyclin like quality
10. Novel prostanoid thromboxane A2 antagonists
11. ChemInform Abstract: RACEMIZATION-FREE INTERCHANGE OF ESTER RADICALS OF AN N-PROTECTED DIPEPTIDE ESTER WITH HELP FROM TITANIUM (IV) ALKOXIDES
12. Stable 9ß- or 11α-halogen-15-cyclohexyl-prostaglandins with high affinity to the PGD2-receptor
13. ChemInform Abstract: E- or Z-Selective Horner-Wittig Reactions of Substituted Bicyclo-(3.3.0)octan-3-ones with Chiral Phosphonoacetates.
14. ChemInform Abstract: Esters of N-(9-Fluorenylmethoxycarbonyl) Amino Acids with 4-Hydroxy-3-oxo-2,5-diphenyl-2,3-dihydrothiophene 1,1-Dioxide (Fmoc-Amino Acid TDO Esters) and Their Use in Solid Phase Peptide Synthesis.
15. Measurements on a Blast-Furnace-Gas and Oil-Fired Combustion Chamber of a 17.25-MWe Closed-Cycle Gas Turbine Plant
16. Novel prostanoid thromboxane A 2 antagonists
17. An attempt to synthesize prostanoid thromboxane A 2 antagonists with an additional prostacyclin like quality
18. ChemInform Abstract: Novel Prostanoid Thromboxane A2 Antagonists.
19. BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe.
20. BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha Therapies.
21. Discovery of the potent non-steroidal glucocorticoid receptor modulator BAY 1003803 as clinical candidate.
22. Structural Evidence for Isoform-Selective Allosteric Inhibition of Lactate Dehydrogenase A.
23. Selective Nonsteroidal Glucocorticoid Receptor Modulators for the Inhaled Treatment of Pulmonary Diseases.
24. Pan-mutant IDH1 inhibitor BAY 1436032 for effective treatment of IDH1 mutant astrocytoma in vivo.
25. Discovery of new selective glucocorticoid receptor agonist leads.
26. Discovery of indazole ethers as novel, potent, non-steroidal glucocorticoid receptor modulators.
27. Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876.
28. Identification of novel GLUT inhibitors.
29. Discovery of quinolines as selective glucocorticoid receptor agonists.
30. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
31. GR ligands: can we improve the established drugs?
32. Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index.
33. Dissociated glucocorticoid receptor ligands: compounds with an improved therapeutic index.
34. Dissociated glucocorticoid receptor ligands.
35. Fluorinated dihydroquinolines as potent n-NOS inhibitors.
36. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
37. Dihydroquinolines with amine-containing side chains as potent n-NOS inhibitors.
38. Dihydroquinolines as novel n-NOS inhibitors.
39. Novel prostanoid thromboxane A2 agonists.
40. Stable 9 beta- or 11 alpha-halogen-15-cyclohexyl-prostaglandins with high affinity to the PGD2-receptor.
41. Stable 9 beta- or 11 alpha-halogen-15-cyclohexyl-prostaglandins with high affinity to the PGD2-receptor.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.